Wally Rapattoni - Janssen Inc | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials

Sheldon W. Tobe,Thomas A. Mavrakanas,Harpreet S. Bajaj,Adeera Levin,Navdeep Tangri,April Slee,Brendon L. Neuen,Vlado Perkovic,Kenneth W. Mahaffey,Wally Rapattoni,Fernando G. Ang

DIABETES CARE（2024）

引用0浏览0WOS引用

Primary and Secondary Cardiovascular and Kidney Prevention with Canagliflozin: Insights from the CANVAS Program and CREDENCE Trial

Abhinav Sharma,Amir Razaghizad,Abdulaziz Joury,Adeera Levin,Harpreet S. Bajaj,G. B. John Mancini, Norman C. Wong,April Slee,Fernando G. Ang,Wally Rapattoni,Brendon L. Neuen,Clare Arnott,Vlado Perkovic,Kenneth W. Mahaffey

JOURNAL OF THE AMERICAN HEART ASSOCIATIONno. 3 (2024)

引用0浏览0WOS引用

Timing of Statistical Benefit of Canagliflozin in Patients with Type 2 Diabetes for Cardiovascular and Heart Failure Outcomes: Insights from the CANVAS Program and CREDENCE Trial

Abhinav Sharma,Pedro Marques,Brendon L. Neuen,Robert A. Fletcher,April Slee,Wally Rapattoni,Fernando G. Ang,Clare Arnott,Adeera Levin,Subodh Verma,Vlado Perkovic,Kenneth W. Mahaffey

DIABETES OBESITY & METABOLISMno. 2 (2024): 758-762

引用0浏览0引用

Kidney Protection with Canagliflozin: A Combined Analysis of the Randomized CANVAS Program and CREDENCE Trials

Vikas S. Sridhar,Brendon L. Neuen,Robert A. Fletcher,April Slee,Fernando G. Ang,Wally Rapattoni,Clare Arnott,David Z. Cherney,Vlado Perkovic,David C. Wheeler,Adeera Levin

Diabetes Obesity and Metabolism（2023）

引用1浏览0WOS引用

Cardiovascular and Kidney Outcomes with Canagliflozin According to Type 2 Diabetes Treatment Targets at Baseline: Data from the CANVAS Programme and CREDENCE

J. Seufert,V. Woo,M. A. Tsoukas,S. W. Tobe,A. Slee,W. Rapattoni,F. G. Ang,D. C. Wheeler

Diabetes, Obesity and Metabolism（2023）

引用0浏览0引用

Effects of Canagliflozin (CANA) on Cardiovascular (CV), Kidney, and Albuminuria Outcomes by Diabetes Duration: Pooled Analysis from the CANVAS Program and CREDENCE

Sheldon W. Tobe,Harpreet S. Bajaj,Adeera Levin,Thomas Mavrakanas,Navdeep Tangri,April E. Slee,Wally Rapattoni,Fernando G. Ang

Journal of the American Society of Nephrologyno. 11S (2022): 674-674

引用0浏览0引用

EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR AND KIDNEY EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH AND WITHOUT PERIPHERAL VASCULAR DISEASE: INTEGRATED ANALYSIS FROM THE CANVAS PROGRAM AND CREDENCE TRIAL

Adeera Levin,Paul Poirier,Jochen Seufert,April Slee,Wally Rapattoni,Fernando Ang,David Wheeler

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022): I892-I893

引用0浏览0引用

856-P: Cardiovascular (CV) and Kidney Outcomes with Canagliflozin (CANA) According to Type 2 Diabetes (T2D) Treatment Targets at Baseline (BL) : Data from the CANVAS Program and CREDENCE

Vincent C. Woo,Michael Tsoukas,Sheldon Tobe,April Slee,Wally Rapattoni,Fernando Ang,Jochen Seufert, David C. Wheeler

Diabetes（2022）

引用0浏览0引用

A Retrospective Observational Population-Based Study to Assess the Prevalence and Burden of Illness of Type 2 Diabetes with an Estimated Glomerular Filtration Rate < 90 Ml/min/1.73 M2 in Ontario, Canada

Wally Rapattoni,David Zante, Marko Tomas,Varun Myageri,Shane Golden,Prerna Grover,Ali Tehrani,Brad Millson,Sheldon W. Tobe,Jennifer B. Rose

Diabetes, obesity & metabolism/Diabetes, obesity and metabolism（2021）

引用3浏览0WOS引用

P0775A RETROSPECTIVE OBSERVATIONAL COHORT STUDY TO ASSESS THE PREVALENCE OF CHRONIC KIDNEY DISEASE AMONG TYPE 2 DIABETES MELLITUS PATIENTS IN ONTARIO, CANADA

Wally Rapattoni,David Zante,Sha Kang,Ali Tehrani,Varun Myageri,Shane Golden,Brad Millson,Jennifer B. Rose

NEPHROLOGY DIALYSIS TRANSPLANTATION（2020）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn